Evidence map›Paper›PMID 37554267›Full record

ArticleTheranostics2023

Click-to-Release: Cleavable Radioimmunoimaging with [

Maria Vlastara, Raffaella Rossin, Freek J M Hoeben, Kim E de Roode, Milou Boswinkel, Laurens H J Kleijn, James Nagarajah, Mark Rijpkema, Marc S Robillard

Abstract read
In one paragraph

Article in Theranostics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Toward Realization of Bioorthogonal Chemistry in the Clinic.Topics in current chemistry (Cham) · 2025
    Review
  11. Article
  12. Article
  13. Scission-Enhanced Molecular Imaging (SEMI).Bioconjugate chemistry · 2024
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria VlastaraTagworks Pharmaceuticals, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands.
Raffaella RossinTagworks Pharmaceuticals, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands.
Freek J M HoebenSyMO-Chem, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.
Kim E de RoodeTagworks Pharmaceuticals, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands.
Milou BoswinkelDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Laurens H J KleijnTagworks Pharmaceuticals, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands.
James NagarajahDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Mark RijpkemaDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Marc S RobillardTagworks Pharmaceuticals, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the main challenges of PET imaging with

Indexed as

NeoplasmsRadioimmunodetectionAnimalsAntibodies, MonoclonalCell Line, TumorCyclooctanesMicePositron-Emission TomographyTrastuzumabZirconiumAntibodies, MonoclonalCyclooctanesTrastuzumabZirconiumclick-to-releaseIEDDAradioimmunoimagingtrans-cyclooctenetrastuzumab

Identifiers

PMID37554267
PMCPMC10405837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.